Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
51.16
+0.80 (1.59%)
Sep 30, 2026, 3:00 PM CST
Chengdu Easton Biopharmaceuticals Employees
Chengdu Easton Biopharmaceuticals had 1,416 employees as of June 30, 2026. The number of employees decreased by 64 or -4.32% since the number was reported on December 31, 2025.
Employees
1,416
Change
-64
Growth
-4.32%
Revenue / Employee
943.39K CNY
Profits / Employee
195.79K CNY
Market Cap
8.88B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 1,416 | -64 | -4.32% |
| Dec 31, 2025 | 1,480 | -42 | -2.76% |
| Dec 31, 2024 | 1,522 | 122 | 8.71% |
| Dec 31, 2023 | 1,400 | 77 | 5.82% |
| Dec 31, 2022 | 1,323 | 135 | 11.36% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pacific Shuanglin Bio-pharmacy | 2,755 |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 2,360 |
| Aurisco Pharmaceutical | 2,026 |
| Vcanbio Cell & Gene Engineering Corp., | 1,935 |
| Jiangxi Fushine Pharmaceutical | 1,663 |
| Liaoning Chengda Biotechnology | 1,585 |
| Daan Gene | 1,506 |
| Bio-Thera Solutions | 1,471 |